Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong, Jae Eun, and Lijun Sun. 2018. “Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.”. Trends in Pharmacological Sciences 39 (3): 307-25.